Clinical Trials Directory

Trials / Completed

CompletedNCT00947063

To Demonstrate the Relative Bioavailability Study of Promethazine HCl 50 mg Tablets Under Fasting Conditions

A Relative Bioavailability Study of Promethazine HCl 50 mg Tablets Under Fasting Conditions

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Sandoz · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

To demonstrate the relative bioavailability study of Promethazine HCl 50 mg tablets under fasting conditions.

Conditions

Interventions

TypeNameDescription
DRUGPromethazine HCl 50 mg Tablets (Sandoz, Inc)
DRUGPhenergan (Promethazine HCl) 50 mg Tablets (Wyeth Laboratories)

Timeline

Start date
2004-07-01
Primary completion
2004-08-01
Completion
2004-08-01
First posted
2009-07-27
Last updated
2017-03-28

Source: ClinicalTrials.gov record NCT00947063. Inclusion in this directory is not an endorsement.